The establishment of the uPA inducible expression system
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [20]
  • | | | |
  • Comments
    Abstract:

    Objective To establish uPA inducible expression system using recombinant retroviral system for the further construction of inducible uPA-SCID animal model. Methods The Inducible expression system need to construct two plasmids:pLNHXO1O2-Alb-GLUC-FMN2A -rtTA and pLNHXO5O6-TRE2-uPA-IRES-ZsGreen respectively. Both plasmids were based on retroviral vector pLNHX, Albumin promoter gene (Alb) and rtTA gene or uPA gene and ZsGreen were obtained by PCR reaction and inserted into pLNHX. The Gaussia enzyme fluorescent element (GLUC) was used to monitor rtTA expression in pLNHXO1O2-Alb-GLUC-FMN2A-rtTA,and the ZsGreen for uPA expression monitoring in pLNHXO5O6-TRE2-uPA-IRES-ZsGreen.The correct constructed plasmids were transfected into packaging cell line GP2-293 to gain recombinant viral particles.NIH/3T3 cells were infected with these viral particles and selected with G418.Gene expression in the surviving cells was confirmed by the PCR method. Results The recombinant retroviral vectors harbouring target genes were successfully cloned.The rtTA gene in pLNHXO1O2-Alb-GLUC-FMN2A-rtTA was expressed, and uPA can be induced to express in pLNHXO5O6-TRE2-uPA-IRES-ZsGreen by doxycycline (Dox) when the plasmid transfected into the HepG-Tet-on cell. The constructed recombinant two retroviral vectors were transfected into GP2-293 packaging cells respectively to gain infectious viral particles.Then,NIH/3T3 cells were infected with these viral particles and single-cell clones which stably expressed the transgenes were successfully established. Conclusion This study primarily established uPA inducible expression system, it laid a foundation for the murine model of inducible liver damage, and provided a novel technical platform for further building the liver humanised murine models for viral hepatitis studying.

    Reference
    [1] Meuleman P,Libbrecht L,De Vos R, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera [J]. Hepatology, 2005,41(4):847-856.
    [2] Song X, Guo Y, Duo S, et al. A mouse model of inducible liver injury caused by tet-on regulated urokinase for studies of hepatocyte transplantation[J]. Am J Pathol, 2009,175(5):1975-1983.
    [3] Heckel JL, Sandgren EP, Degen JL, et al. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator[J]. Cell, 1990,62(3):447-456.
    [4] Sandgren EP,Palmiter RD,Heckel JL, et al. Complete hepatic regeneration after somatic deletion of an Albumin-plasminogen activator transgene[J]. Cell, 1991,66(2):245-256.
    [5] Philip Meuleman, Geert Leroux-Roels. The human liver-uPA-SCID mouse:A model for the evaluation of antiviral compounds against HBV and HCV[J]. Antiviral Research, 2008,80(3): 231-238.
    [6] Trépo C, Chan HL, Lok A. Hepatitis B virus infection[J]. Lancet, 2014,Jun 18.(14)60220-60228.
    [7] Guidotti LG,Rochford R,Chung J, et al. Viral clearance without destruction of infected cells during acute HBV infection[J]. Science, 1999,284(5415):825-829.
    [8] Baumert TF, Yang C, Schürmann P, et al. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes[J]. Hepatology, 2005,41(2):247-256.
    [9] Lin E, Luscombe C, Colledge D, et al. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo[J]. Antimicrob Agents Chemother, 1998,42(8):2132-2137.
    [10] Dandri M,Lutgehetmann M,Volz T, et al. Small Animal Model Systems for Studying Hepatitis B Virus Replication and Pathogenesis[J]. Seminars in liver disease, 2006,26(2):181-191.
    [11] Kimura K,Kakimi K,Wieland S, et al. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice[J]. J Virol, 2002,76(21):10702-10707.
    [12] Robek MD,Boyd BS,Wieland SF, et al. Signal transduction pathways that inhibit hepatitis B virus replication [J]. Proc Natl Acad Sci USA, 2004,101(6):1743-1747.
    [13] Guidotti LG,Matzke B,Schaller H, et al. High-Level Hepatitis B Virus Replication in Transgenic Mice[J]. Journal of Virology, 1995,69(10):6158-6169.
    [14] Liu F,Song Y,Liu D, et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA[J]. Gene Therapy, 1999,6(7):1258-1266.
    [15] Yang PL,Althage A,Chung J, et al. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection[J]. Proc Natl Acad Sci USA, 2002,99(21):13825-13830.
    [16] Konishi M,Tanaka H,Kaito M, et al. Ultrastructural demonstration of hepatitis B virus production in a mouse model produced by hydrodynamic transfection[J]. Int J Mol Med, 2007,20(1):31-36.
    [17] Huang LR,Wu HL,Chen PJ ,et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J]. Proc Natl Acad Sci USA, 2006,103(47):17862-12867.
    [18] De Jong YP, Rice CM, Ploss A. New horizons for studying human hepatotropic infections[J]. J Clin Invest, 2010,120(3):650-653.
    [19] 张一,黎晓敏,吕凤林,等. Cre/Loxp和四环素系统在基因可控表达中的应用[J]. 中国实验动物学报, 2007,(1):76-80.
    [20] 杨丽华,周常文. Tet-on调控的基因表达载体的构建与体外表达研究[J]. 徐州医学院学报, 2011,(2):81-83.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:1777
  • PDF: 1793
  • HTML: 0
  • Cited by: 0
History
  • Revised:November 20,2014
  • Online: January 29,2015
Article QR Code